|
HS Code |
768227 |
| Cas Number | 372-94-9 |
| Molecular Formula | C4H7FO2 |
| Molecular Weight | 106.10 g/mol |
| Iupac Name | 4-fluorobutanoic acid |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 190-193 °C |
| Melting Point | -24 °C |
| Density | 1.135 g/cm³ |
| Solubility In Water | Miscible |
| Flash Point | 83 °C |
| Pka | 4.76 |
| Synonyms | 4-Fluorobutanoic acid |
As an accredited 4-Fluorobutyric Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 500g, tightly sealed with a screw cap, labeled “4-Fluorobutyric Acid,” hazard pictograms, and handling instructions. |
| Shipping | 4-Fluorobutyric acid is shipped in secure, airtight containers to prevent leaks and contamination. Handle as a hazardous material, following all local, national, and international regulations for transportation. Containers must be labeled appropriately and stored in a cool, dry place away from incompatible substances during transit. Use appropriate protective measures when handling. |
| Storage | 4-Fluorobutyric acid should be stored in a tightly sealed container, kept in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents and bases. Protect from moisture and direct sunlight. Store at room temperature, ideally between 15-25°C. Ensure appropriate chemical labeling and secondary containment to prevent leaks or accidental exposure. |
Applications of 4-Fluorobutyric Acid in Industrial Manufacturing4-Fluorobutyric acid supports specialized manufacturing sectors as a key intermediate, contributing specifically to complex synthesis protocols where fluorinated building blocks confer unique chemical and physical properties to downstream products. The following sections outline main industrial applications, process considerations, and output categories based on actual market demands and sector compliance. 1. Pharmaceutical Intermediate for Anticonvulsant API SynthesisOur material serves as a fluorinated precursor in the synthesis pathway for certain anticonvulsant active pharmaceutical ingredients (APIs). Customers integrate this raw material in multistep processes to introduce precise fluorine substitutions, facilitating pharmacokinetic modifications for next generation central nervous system therapeutics. Input material purity directly impacts downstream reaction yields and regulatory compliance for large-scale pharmaceutical manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Intermediate for Agrochemical Active Ingredient ProductionThe material functions as a building block in fluorinated agrochemical actives, particularly within herbicide and plant growth regulator synthesis. Direct fluorine incorporation enhances active compound stability in field applications and influences metabolic breakdown. Producers value consistent lot-to-lot purity for scaling seasonal production batches and regulatory dossiers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fluorinated Monomer Synthesis for Specialty PolymersSpecialty polymer producers leverage 4-fluorobutyric acid for manufacturing advanced fluorinated monomers. These monomers contribute unique hydrophobic and chemical barrier properties to end-use polymer systems. Precision input control ensures chain uniformity and maintains performance characteristics across production runs aimed at highly regulated technical applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Building Block in Advanced Organic SynthesisFine chemical manufacturers use this raw material as a C4 fluorinated synthon to construct advanced intermediates for both R&D and commercial synthesis. Chemists exploit the robust fluorine-carbon bond to enable further derivatization under anhydrous or inert atmosphere. Material is favored when constructing scaffolds for custom research molecules, especially in flavor, fragrance, or advanced material innovation where precise substitution influences downstream function. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Starting Material for PET Tracer Synthesis in Nuclear MedicineNuclear medicine research centers and radiopharmaceutical manufacturers use our 4-fluorobutyric acid as a starting scaffold for short-lived positron emission tomography (PET) tracers. The fluorine atom facilitates site-specific radioisotope labeling, which supports molecular imaging protocols. Production takes place in controlled, GMP-compliant environments to guarantee suitability for clinical and preclinical tracing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Fluorobutyric Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in chemical production brings a unique perspective on what separates a high-purity intermediate from generic commodity reagents. In the case of 4-Fluorobutyric Acid, every batch comes with history—struggles at the reactor, close analysis of side products, hard decisions at quality control. Our experience with this compound goes back years, and the lessons haven't been trivial. Consistency in composition, strict corrosivity management, and environmental controls underscore every day of manufacturing.
4-Fluorobutyric Acid, also known by its CAS number 140-75-0, is a colorless, strong-smelling liquid. The presence of a fluorine atom on the butyric acid backbone makes for both opportunity and challenge. Unlike unsubstituted butyric acid, this compound does not simply exchange into most reaction schemes. Careful handling and specialized synthetic routes keep its high purity above 99%. Based on repeated analysis by both GC and NMR—critical for our downstream customers—stubborn byproducts such as isobutyric and trifluorobutyric derivatives are held consistently below threshold. Bulk density and refractive index control serve as quick on-line checks, but it’s the tight proton NMR envelope that gets the batch out the door.
Its value goes far beyond the sum of its atoms. We see how researchers in pharmaceuticals keep struggling to build stable, targeted compounds. Our 4-Fluorobutyric Acid doesn’t just join a list of reagents—it opens up a fluorinated linker at exactly the right place in new drug candidates. The fluorine substitution fundamentally alters metabolic pathways, giving improved bioavailability or adjusting the pKa for binding to active sites. In my years watching customers trial alternatives, the impact of this single atom swap shows up in cleaner spectra, more stable intermediates, and even in reduced animal study dropout rates.
We quickly learned that not all fluorination reagents deliver the same results downstream. Hydrogen fluoride-based chemistries tempted us early, but corrosion demanded overloads of Inconel and Teflon—excellent for a pilot batch, unworkable for scale. Alkali-mediated routes, on the other hand, impacted the enantiopurity of subsequent reaction products. After troubleshooting repeated color and odor inconsistencies, team input led us to flow-based methodologies that sharply control heat and reaction time. The same sequence achieves higher throughput and longer media life, a major cost win that we pass down. Waste treatment, especially of spent fluorination agents, needed more than standard acid neutralization. Closed-loop recycling now keeps emissions far below local limits.
Too many buyers have lost time and money chasing low-cost or off-spec shipments. Our 4-Fluorobutyric Acid meets industry standards for GC area purity (≥99.5%) and water content (below 0.1% by Karl Fischer), but the numbers alone don’t drive our production. We check batch-to-batch odor, because even non-critical impurities can compromise catalyst longevity. The melting and boiling ranges (8–10°C and 161–163°C under atmospheric pressure) are verified with each lot—not to populate a data sheet, but because trace deviations hint at side reactions not picked up by chromatography. We’ve continued to refine glassware and transfer lines after seeing how minor metallic impurities alter downstream reactivity, especially in the formation of amides or esters.
Unlike basic building-block acids, 4-Fluorobutyric Acid isn’t a bulk commodity tossed into a primary reactor. Its value shows up when selectivity and predictable behavior matter above all else. Medicinal chemists rely on it to introduce a fluorinated butyrate group without scrambling the rest of the molecule. Agrochemical developers reserve it for formulation work that depends on introducing both lipophilicity and hydrolytic stability. Polymer specialists look to the acid to tweak side-chain properties in specialty materials, seeking to balance flexibility with solvent resistance. Each group asks for repeat performance—not just “within spec,” but with no surprises or batch-to-batch learning curves that slow their projects. Our records track not just outgoing analyses, but also downstream applications as relayed to us in return feedback. We’re always looking for new application notes or case studies that show the real-world advantages.
We get regular inquiries comparing 4-Fluorobutyric Acid to the more common trifluoroacetic or monofluoroacetic alternatives. Those compounds differ sharply in reactivity and toxicology. Trifluoroacetic acid, for example, boasts aggressive acidity and volatility, complicating its use in high-value intermediates or in situations that require controlled hydrolysis. Monofluoroacetic acid introduces significant mammalian toxicity, making workplace controls much more difficult. Our 4-Fluorobutyric Acid achieves a mild acidity (pKa ~4.7) and a responsible safety profile, requiring standard acid handling rather than specialty respiratory equipment. Companies in fine chemicals see value in this balance, obtaining fluorinated benefits without the baggage of extreme volatility or hazard.
Years of working with pharmaceutical and research partners have hammered home one point: surprises in intermediate quality stop projects cold. Our technical team fields calls on batch-to-batch consistency. The GC and NMR profiles matter, but so do “soft” factors like trace impurities, batch color, and even shipping temperatures. A single out-of-spec shipment in 2019 spurred an upgrade of our in-process controls. By logging every deviation, down to operator comments and chromatogram overlays, we built a feedback system that actually guides future production. The innovation came not from one-off fixes, but by weaving returned customer vials into our own analytical loop.
We’ve found that the end use of 4-Fluorobutyric Acid dictates far more about packaging than most technical sheets admit. Polymer chemists want glass for analytical scale work, pharmaceutical developers expect sealed, inert-packed drums at larger scale due to long-term shelf stability requirements. We spent months trialing linings and closures, checking not only the interaction with the acid but the trace leaching over time. Our feedback cycle comes largely from research labs pushing us for unrefrigerated, “grab-and-dose” containers versus the kilo-scale contractors who stockpile material for campaign work. By keeping these contexts in mind, our team doesn’t treat packaging as a formality, but as a real point of product differentiation.
Routine purity checks don’t tell the whole story. Each GC trace is scrutinized for the tiniest wisp of extra peaks—sometimes even the ones falling just under the noise. Many decades in the lab have taught us that these low-level impurities creep up most during scale-ups or “recipe shifts.” By overlaying historical NMR and MS plots, minor changes in the spectrum are traced back to feedstock lots or minor mechanical issues in the processing line, not just a bad day in the dry room. Still, every so often, a chromatographic outlier emerges, always followed by deep-dive root cause work that pushes process improvement for all following batches. It’s not just about “passing QC,” but about knowing exactly what happened—and stopping it from repeating.
Fluorinated intermediates raise real environmental questions. We field customer inquiries on lifecycle analysis, as fluorinated moieties tend to persist. Our manufacturing plant invested in an advanced capture system to prevent traces of fluorine-containing side streams from leaving the property. Internally, we track full cradle-to-gate metrics, not for marketing, but because compliance requires foresight in our line of work. By connecting our QA and environmental teams, we ensure not a single shipment leaves untracked, and any surprise findings trigger a review involving both fields. Regulatory review, especially for exports, costs time and money both for us and for our customers. Each file is built from batch history, not copy-paste text blocks. Down the line, we help customers complete their own documentation—not because regulations force it, but because missing data can stop a project faster than any chemical impurity.
Each year our operators bring forward adjustments that seem minor but compound over time. A tweak in distillation column operation, a refined wash cycle after fluorination, or a new sensor to catch trace levels of HCl or SO2—these come not from consultants or formal “best practices,” but from standing forty hours a week on the production floor. Management schedules regular feedback workshops just for stories from line staff, whose keen eyes for habit and pattern catch trends missed by weekly reporting. Taking pride in product quality means seeing exactly where flaws originate, not hiding them under paperwork or wishful thinking.
The way a fluorinated intermediate behaves in a downstream process can make or break an entire project. Chemists and engineers share stories of time lost troubleshooting unknown batch-to-batch variation. Over the years, we have learned firsthand that eliminating these surprises pays dividends downstream. Whether in custom peptide synthesis, exploratory drug modification, or field trials in polymer blends, the clock runs faster when inputs behave as expected. Our own teams have seen painstaking trial-and-error shrink to robust, repeatable protocols just by getting reliable material in the door every time.
We thrive on hearing where our 4-Fluorobutyric Acid ends up beyond the plant gates. A recent collaboration with a university spinout studying fluorinated GABA analogues highlighted batch consistency as the single most valuable asset. Slight shifts in impurity ratios significantly impacted animal study outcomes—even in non-GMP research. Over years of back-and-forth, we tuned analytical protocols informed directly by their pharma screens, feeding improvements back into process development. Across the Atlantic, a polymer customer demonstrated how trace chloride impurities, long thought irrelevant, subtly influenced material color and aging in solar performance trials. Transferring that lesson back to our operation led to extra wash cycles and a noticeable uptick in customer satisfaction.
Maintaining a stable inventory of 4-Fluorobutyric Acid demands more than stacking drums on a rack. We track physical age, monitor headspace for vapor phase impurities, and test stored batches before release. Field experiences have shown that improper storage conditions or missed retest windows can reduce apparent purity and change downstream results. Every time a bottle leaves for shipment, it comes freshly sampled and verified, regardless of inventory compile dates. Our customers often run campaigns dependent on predictability, and our inventory methods were tuned with these needs in mind.
No two campaigns run the same way, and we get regular technical support calls about integrating 4-Fluorobutyric Acid into complex synthesis routes. Our real advantage lies in troubleshooting with practical knowledge, not just search-engine answers. Sometimes the answer lies in trace impurity profiles; at other times, subtle pH effects or interaction with specific solvents make the difference. We use every post-market issue as a lesson—consulting run records, pulling retained samples, matching reactivity data between batches to uncover the real underlying story. This active cycle forms the backbone of our product reliability.
Production of specialized building blocks like 4-Fluorobutyric Acid doesn’t stand still. Requirements from research and industry keep changing, calling for not just higher purity or lower cost, but also different physical formats, documentation to fit new regulatory frameworks, and deeper collaboration on analytics. Our ongoing focus is to keep evolving, investing in equipment, people, and feedback processes that anticipate rather than react. The dialogue with end users continues to shape our batch validation and release criteria, making the product stronger every cycle.
What distinguishes our 4-Fluorobutyric Acid isn’t a list of bullet-point specs or a certificate of analysis. It’s the sum of daily choices to maintain purity, absorb customer feedback, and practice true troubleshooting at scale. From careful sourcing and reaction control to transparency in documentation and commitment to ongoing process improvement, the value of the final product reflects the discipline of the operation behind it. Looking back, the toughest production days taught us the most, reminding us that every gram delivered carries more than just the molecule—it carries the experience, pride, and reliability built up over years of hands-on chemical manufacturing.